Adjust in time: beware of the challenges Annex VI brings for labelling
Gordon Alexander and Simon Jones outline how imminent changes to EU clinical trial regulations will have major implications for labelling processes.
ALREADY A REGISTERED USER? SIGN IN now
REGISTER FOR FREE TO CONTINUE READING THIS ARTICLE
And get access to unlimited world-class packaging reporting and commentary.